Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
September 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
September 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Kosuke Iwasaki, FIAJ, MAAA
Consulting Actuary,
Milliman,
New York, NY
Consulting Actuary, Milliman, New York, NY
Authored Items
Resource Utilization and Cost in a Commercially Insured Population with Schizophrenia
Kathryn Fitch, RN, MEd
,
Atheer A. Kaddis, PharmD
,
Kosuke Iwasaki, FIAJ, MAAA
,
Kathleen F. Villa, MS
January/February 2014 Vol 7, No 1
in
Business
The Incidence Rate and Economic Burden of Community-Acquired Pneumonia in a Working-Age Population
Jonah Broulette, ASA, MAAA
,
F. Randy Vogenberg, PhD, FASHP
,
Holly Yu, MSPH
,
Kosuke Iwasaki, FIAJ, MAAA
,
Reiko Sato, PhD
,
Bruce S. Pyenson, FSA, MAAA
September/October 2013, Vol 6, No 8
in
Business
National Burden of Preventable Adverse Drug Events Associated with Inpatient Injectable Medications: Healthcare and Medical Professional Liability Costs
Betsy J Lahue, MPH
,
Jaan Sidorov, MD, MHSA
,
Bruce S. Pyenson, FSA, MAAA
,
Kosuke Iwasaki, FIAJ, MAAA
,
Helen Blumen, MD, MBA
,
Susan Forray, FCAS, MAAA
,
Jeffrey M. Rothschild, MD, MPH
November/December 2012 Vol 5, No 7
in
Clinical
Utilization of Anticoagulation Therapy in Medicare Patients with Nonvalvular Atrial Fibrillation
Delete Delete
,
Jonah Broulette
,
Bruce S. Pyenson, FSA, MAAA
,
Kosuke Iwasaki, FIAJ, MAAA
,
Winghan Jacqueline Kwong, PharmD, PhD
,
Michael F. Murphy, MD, PhD
May/June 2012, Vol 5, No 3
in
Business
Estimates of Commercial Population at High Risk for Cardiovascular Events: Impact of Aggressive Cholesterol Reduction
Kathryn Fitch, RN, MEd
,
David Williams
,
Sara W. Goldberg, FSA, MAAA
,
Kosuke Iwasaki, FIAJ, MAAA
,
Bruce S. Pyenson, FSA, MAAA
,
Andreas Kuznik, PhD
,
Henry A. Solomon, FACP, FACC
September/October 2009, Vol 2, No 6
in
Clinical
Last modified: October 24, 2013